References
- Kymes SM. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases. Ophthalmic Epidemiol 2008;15:76–83
- Drummond MF, Schulpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005
- Starting a new phase – European network for HTA Joint Action. 2009. Accessed July 5, 2010 from http://www.eunethta.net/upload/Joint%20Action/JA%20WP1/GrantAgreement%20Tech%20Annex/JA_Annex%201%20-%20part%201.pdf
- Appleby J, Devlin N, Parkin D. NICE’s cost effectiveness threshold. BMJ 2007;335(7616):358–359
- Canadian Agency for Drugs and Techonology in Health. Guidelines for the economic evaluation of health technologies. Ottawa, Canada: Canadian Agency for Drugs and Techonology in Health; 2006
- Kymes SM, Lee BS. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007;84:809–816
- Torrance GW. Preferences for health outcomes and cost-utility analysis. Am J Manag Care 1997;3(Suppl.):S8–20
- Brooks R, Rabin R, De Charro F. The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht: Kluwer; 2003
- Feeny DH, Furlong WJ, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 System. Med Care 2002;40:113–128
- Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050–1058
- Kay S, Ferreira A. Mapping the National Eye Institute 25-item Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Ophthalmic Epidemiol 2014;21:66–78
- Feeny D. The Health Utilities Index: a tool for assessing health benefits. USA: Institute of Medicine; 2005
- EuroQol Group. EuroQol* – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208
- Rentz AM, Kowalski JW, Walt JG, et al. Development of a Preference-Based Index From the National Eye Institute Visual Function Questionnaire-25. JAMA Ophthalmol Jan 16 2014 [Epub ahead of print]
- Espallargues M, Czoski-Murray CJ, Bansback NJ, et al. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci 2005;46:4016–4023
- Kaplan RM, Tally S, Hays RD, et al. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J Clin Epidemiol 2011 May;64(5):497--506
- Lee BS, Kymes SM, Nease RF, Jr, et al. The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology 2008;115:898–903 e894
- Will the QALY Survive? Panel Discussion at the 11th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 20–24, 2006; Philadelphia, PA
- Johnson FR. Einstein on willingness to pay per QALY: is there a better way? Med Decis Making 2005;25:607–608